Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study

NCT: NCT03794011 · ACTIVE_NOT_RECRUITING

NCT IDNCT03794011
StatusACTIVE_NOT_RECRUITING
Start Date2018-12-18
Completion2027-12
SponsorBaylor College of Medicine (OTHER)
First posted
Last updated

Brief Summary

The purpose of the study is to compare the maternal, fetal and neonatal outcomes of a cohort of 60 patients in whom a multilayer closure with a Durepair patch is performed with a prior cohort of patients in whom a standardized repair without patch (n = 32) was performed using the same minimally invasive fetoscopic repair technique. The hypothesis is that there will be a thicker repair (as measured by MRI at 6 weeks post surgery) and less MMC repair dehiscence and/or CSF leak with the patch repair.

Frequently Asked Questions

What is Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study?

Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study is a clinical trial registered under NCT03794011. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03794011?

The current status of NCT03794011 (Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study) is: ACTIVE_NOT_RECRUITING.

When did Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study start?

Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study started on 2018-12-18.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑